文献速递临床微生物质量管理与危急值

新型抗葡萄球菌裂解酶Exebacase的MIC质控参数测定

Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity.
PubMed 文献 · J Clin Microbiol · 2021-06-18

Exebacase(CF-301)是首个进入3期临床(NCT04160468)的抗葡萄球菌裂解酶,用于治疗金黄色葡萄球菌菌血症。研究按CLSI M23定义的2级质控方法,以金黄色葡萄球菌ATCC 29213和粪肠球菌ATCC 29212为参考菌株,建立新参考肉汤微量稀释法的质控范围,并经CLSI抗菌药物敏感性试验分委员会批准。

要点

  • Exebacase对金黄色葡萄球菌ATCC 29213的质控范围为0.25–2 μg/ml。
  • 对粪肠球菌ATCC 29212的质控范围为8–64 μg/ml。
  • 质控范围跨4个log2稀释度,覆盖99.2%的MIC结果。

核心结论

  • 建立的Exebacase肉汤微量稀释法质控范围经CLSI批准,可确保临床开发中药敏试验的性能和结果准确性。

研究设计与样本

  • 多实验室CLSI M23定义的2级质控研究,参考菌株为金黄色葡萄球菌ATCC 29213和粪肠球菌ATCC 29212。

主要发现

  • Exebacase肉汤微量稀释MIC质控范围跨4个log2稀释度,包含两株参考菌株99.2%的MIC结果。

关键数值与推荐

  • 对金黄色葡萄球菌ATCC 29213的质控范围为0.25至2 μg/ml。
  • 对粪肠球菌ATCC 29212的质控范围为8至64 μg/ml。

临床怎么用

  • 使用参考肉汤微量稀释法进行Exebacase药敏试验时,应以相应质控范围监控检测性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Exebacase (CF-301), a novel, antistaphylococcal lysin (cell wall hydrolase) is the first agent of this class to enter late-stage clinical development (phase 3, NCT04160468) for the treatment of Staphylococcus aureus bacteremia, including right-sided endocarditis. A multilaboratory Clinical and Laboratory Standards Institute (CLSI) M23-defined tier 2 quality control (QC) study was conducted to establish exebacase QC ranges for a new reference broth microdilution method. S. aureus ATCC 29213 and Enterococcus faecalis ATCC 29212 were selected as reference QC strains. Broth microdilution MIC QC ranges for exebacase spanned 4 log2 dilutions and contained 99.2% of the MIC results generated for the two reference strains. The QC ranges for exebacase were defined as 0.25 to 2 μg/ml and 8 to 64 μg/ml against S. aureus ATCC 29213 and E. faecalis ATCC 29212, respectively, and were approved by the CLSI Subcommittee on Antimicrobial Susceptibility Testing. These QC ranges established for use with the reference broth microdilution method developed for exebacase susceptibility testing will ensure the test performance and accuracy of results generated during clinical development.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Traczewski MM, Ambler JE, Schuch R, et al. Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity. J Clin Microbiol. 2021. PMID: 33910968. doi:10.1128/JCM.03117-20

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。